To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

ACUVUE® OASYS with Transitions™

ACUVUE® OASYS with Transitions™

ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ is the first-of-its-kind contact lens to deliver superior visual performance your patients can see and feel.*1

 

Effective March 8, 2024, diagnostic lenses for ACUVUE® OASYS with Transitions™ will no longer be available.

Effective June 30, 2024, revenue lenses for ACUVUE® OASYS with Transitions™ will no longer be available.

Read Full Communication Here > Link to Letter

 

 

ACUVUE® OASYS with Transitions Light Intelligent Technology is the first-of-its-kind contact lens to deliver superior visual performance your patients can see and feel.*1 This lens combines the proven comfort of ACUVUE® with seamless adaptation to light for superior visual performance, day to night.*1,2,3

Click here to discover the Seven Dimensions

Some of the many benefits this contact lens provides to your patients:

  • Reduces stressful impact of bright light*,#,2 
  • Reduces haloes by up to 18% and starbursts by up to 28% at night*2  
  • Seamlessly adapts to light, indoors and out3
  • Blocks up to 15% of blue light indoors and up to 55% outdoors, where your patients need it most^, ¥,3
  • ACUVUE® OASYS with Transitions™ was preferred nearly 3 to 1 over the leading reusable contact lens*4

8.4 mm base curve/14.0 mm diameter

8.8 mm base curve/14.0 mm diameter

Note: 8.8 base curve revenue only

Power Ranges

–6.00 D to +6.00 D (0.25 D steps)

+6.50 D to +8.00 D (0.50 D steps)

–6.50 D to –12.00 D (0.50 D steps)

Including plano

Lens Material Senofilcon A (38%)
Technology Silicone hydrogel HYDRACLEAR® PLUS Light Intelligent Technology™
Dk/t (edge-corrected) 121x10^-9
Water content 38%
UV blocker Class 1
Centre thickness at –3.00 D (mm) 0.085
Inside-out mark Yes
Visibility tint Yes
Package size 6 lenses

7 Dimensions For Superior Visual Performance*1

COMFORT
1. Physical comfort
Developed on ACUVUE® OASYS platform, unbeaten in comfortλ3

VISION
2. Vision at night
Reduces haloes by up to 18% and starbursts by up to 28% at night*2

3. Colour contrast
Provides up to 38% better colour contrast*2

4. Vision in bright light, indoors and out
Reduces stressful impact of bright light*,#,2 

LIGHT MANAGEMENT
5. Active blue light filtering^
Blocks up to 15% of blue light indoors and up to 55% outdoors, where your patients need it most¥3

6. UV protection‡,∞
Highest level of UV protection in a contact lens (blocks 100% of UVB and >99% of UVA)3,6

7. Adaptation to changing light
Seamlessly adapts to light, indoors and out3

*Compared to ACUVUE® OASYS with HYDRACLEAR® PLUS.

λwww.clinicaltrials.gov is a website maintained by the NIH. The 21 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-weekly and ACUVUE® OASYS with Transitions™ Light Intelligent Technology™. Review conducted as of October 2, 2019.

Clinical trials have shown those aged 40-65 may be more likely to experience this benefit in the inactivated ACUVUE® OASYS with Transitions™ lens.

#By helping your vision recover from bright light faster and reducing squinting.

^Calculated per ISO-8980-3 for 380-460nm (Blue Light Hazard Function B(lambda)).

¥These measures are calculated within the range where you have the highest energy across the blue light hazard.

 

References:

1. JJV Data on File 2018. ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ – Objective and Subjective Clinical.

2. JJV Data on File 2018. ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ – Objective Clinical Claims.

3. JJV Data on File 2018. Definition of ACUVUE® OASYS with Transitions™ Light Intelligent Technology™.

4. JJV Data on File 2018. ACUVUE® OASYS with Transitions™ Subjective Clinical Evaluation of two silicone hydrogel reusable contact lenses. 6-week dispensing evaluation, n=239 soft CL wearers in the U.S.​

5. JJV Data on File 2018. ACUVUE® Master Brand Claims on Clinical Performance and Overall Material Properties.

6. JJV Data on File 2018. Material Properties: ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR® PLUS ACUVUE® OASYS with Transitions™ Light Intelligent Technology™ and Other Reusable Contact Lenses.

 

‡Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

∞WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders.

Lenses are not a replacement for sunglasses.

 

Important safety information:

ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from Johnson & Johnson Vision Care division of Johnson & Johnson Inc., by calling 1-800-267-5098 or by visiting jnjvisionpro.ca.

Transitions, the Transitions logo and Transitions Light Intelligent Technology are trademarks of Transitions Optical, Inc. used under license by Transitions Optical Limited and Johnson & Johnson Vision Care, Inc.

 

© Johnson & Johnson Vision Care division of Johnson & Johnson Inc. 2019

PP2019AOT4236 December 2019